Resources

Discover a quick approach to de-risk your injectable therapeutic candidates using ex vivo live human skin.

Explore InflammaSkin^®, a unique T cell-driven skin inflammation platform to test your topical anti-psoriasis formulas.

Uncover InflammaSkin^®, a unique T cell-driven skin inflammation platform to test your injecatble anti-psoriasis formulas.

Ask the Expert: Your Top Questions About Genoskin’s Mast Cell Platform Answered Curious about mast cells and their role in injection site reactions? Learn about how Genoskin sources and cultures human primary mast cells, the unique qualities of our mast cell research solution, and its diverse applications in drug toxicity assessment, allergic reaction evaluation, and vaccine development. 1. How doRead more

Assessment of injection site reactionsA new proprietary research tool to identify drug-related immune adverse reactions in human skinToday, biologics represent one of the fastest growing markets within the pharmaceutical industry.The pipeline of biological drugs is growing at a rapid pace with a global market expected to reach over 460 billion USD in 2024 (1). In order to bypass gastric metabolism,Read more

Navigating Unwanted ImmunogenicityPart 3 - Challenges & insights in biologic drug developmentOver the past two and a half decades, biologics development has been growing exponentially, matching the pace of small molecules development in 20221. Biologics, or biopharmaceutical products, encompass a wide range of therapeutic products such as vaccines, monoclonal antibodies, gene and cell therapy, and recombinant and fusion therapeutic proteins.Read more